Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27567279

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2016 Oct 15
First author
Zhang L

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Oct 15;388(10054):1853-1854. doi: 10.1016/S0140-6736(16)31394-0.
    note
    Source null
    related pmid
    27567280
    relationship
    Comment in
  2. citation
    Lancet. 2016 Oct 15;388(10054):1882. doi: 10.1016/S0140-6736(16)31808-6.
    note
    Source null
    related pmid
    27751398
    relationship
    Erratum in

Authors and identifiers

  1. name
    Zhang L
    type
    Author
  2. name
    Huang Y
    type
    Author
  3. name
    Hong S
    type
    Author
  4. name
    Yang Y
    type
    Author
  5. name
    Yu G
    type
    Author
  6. name
    Jia J
    type
    Author
  7. name
    Peng P
    type
    Author
  8. name
    Wu X
    type
    Author
  9. name
    Lin Q
    type
    Author
  10. name
    Xi X
    type
    Author
  11. name
    Peng J
    type
    Author
  12. name
    Xu M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Zhang L
    type
    Author
  2. name
    Huang Y
    type
    Author
  3. name
    Hong S
    type
    Author
  4. name
    Yang Y
    type
    Author
  5. name
    Yu G
    type
    Author
  6. name
    Jia J
    type
    Author
  7. name
    Peng P
    type
    Author
  8. name
    Wu X
    type
    Author
  9. name
    Lin Q
    type
    Author
  10. name
    Xi X
    type
    Author
  11. name
    Peng J
    type
    Author
  12. name
    Xu M
    type
    Author
bibliography ids
  1. nci-bib-5cc4ea9b453973b827cd84db
book metadata
content sha256
9c199af1b11273432f0571827685f7cd731cce09a128bfbc10c5aaaa51e53b4c
document type
citation
dois
  1. 10.1016/S0140-6736(16)31388-5
electronic publication date
display
2016 Aug 23
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27567279
immutable id
pubmed:27567279@9c199af1b11273432f0571827685f7cd731cce09a128bfbc10c5aaaa51e53b4c
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10054
name
Lancet (London, England)
nlm unique id
2985213R
pages
1883-1892
volume
388
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Oct 15;388(10054):1853-1854. doi: 10.1016/S0140-6736(16)31394-0.
    note
    Source null
    related pmid
    27567280
    relationship
    Comment in
  2. citation
    Lancet. 2016 Oct 15;388(10054):1882. doi: 10.1016/S0140-6736(16)31808-6.
    note
    Source null
    related pmid
    27751398
    relationship
    Erratum in
outcomes validated
false
pmid
27567279
provenance
batch id
d649bcb2d98dbbacd53c
provider
NCBI PubMed ESummary
record sha256
c8aa3d7bda188d536e5ed2ce4c62b23c579bc623d8a643a6fb63ff4d15579987
response sha256
26648a40f123f366675007f51cc29befd1f9a89273ca2da87c477c54d2d15d20
retrieved at
2026-09-09T23:47:20.761544+00:00
publication date
display
2016 Oct 15
precision
day
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27567279/
title
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.

Preserved source evidence · Not medical advice